|
|
|||||||||||||||||||||||||||||||||||||||
Current Fiscal Year DataIn 1984 a group of distinguished trustees appointed by the Delaware Court of Chancery assumed responsibility for the Institute and reaffirmed its primary purpose of basic medical research. They guided the Institute through the sale of the Hughes Aircraft Company on December 20, 1985, creating the endowment that is its principal source of funding. This reorganization and sale of Hughes Aircraft marks the beginning of the modern era of Institute activities, and serves as the starting point for the presentation of cumulative expenditure information. At the end of fiscal year 2012, the Institute had $16.1 billion in diversified net assets, making it the nation's largest private supporter of academic biomedical research.
Questions or comments about information contained in the Institute's audited financial statements should be directed to Nitin Kotak, Vice President and Chief Financial Officer or to Monique Marcus, Assistant Controller.
|
|||||||||||||||||||||||||||||||||||||||